重组凝血因子VIIa应用于产科大出血。 - Suppr

Suppr

超能文献

Recombinant factor VIIa should be used in massive obstetric haemorrhage.

作者信息

Van de Velde M

机构信息

Department of Anaesthesiology, Katholieke Universiteit Leuven and University Hospitals Gasthuisberg, Leuven, Belgium.

出版信息

Int J Obstet Anesth. 2007 Oct;16(4):357-9. doi: 10.1016/j.ijoa.2007.06.002. Epub 2007 Aug 15.

DOI:10.1016/j.ijoa.2007.06.002

PMID:17702565

Abstract

摘要

相似文献

Recombinant factor VIIa should be used in massive obstetric haemorrhage.

Int J Obstet Anesth. 2007 Oct;16(4):357-9. doi: 10.1016/j.ijoa.2007.06.002. Epub 2007 Aug 15.

Recombinant factor VIIa should be used in massive obstetric haemorrhage.

Int J Obstet Anesth. 2007 Oct;16(4):354-7. doi: 10.1016/j.ijoa.2007.06.001. Epub 2007 Aug 14.

Recombinant factor VIIa in massive postpartum haemorrhage.

Int J Obstet Anesth. 2007 Jan;16(1):29-34. doi: 10.1016/j.ijoa.2006.09.001. Epub 2006 Nov 27.

Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.

Aust N Z J Obstet Gynaecol. 2008 Aug;48(4):447. doi: 10.1111/j.1479-828X.2008.00897.x.

Recombinant factor VIIa in massive obstetric haemorrhage.

Eur J Anaesthesiol. 2008 Mar;25(3):250-1. doi: 10.1017/S0265021507002712.

Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature.

BJOG. 2004 Mar;111(3):284-7. doi: 10.1111/j.1471-0528.2004.00058.x.

Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.

Pharmacoeconomics. 2007;25(12):1007-29. doi: 10.2165/00019053-200725120-00004.

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.

Anesth Analg. 2009 Dec;109(6):1908-15. doi: 10.1213/ANE.0b013e3181c039e6.

Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.

BioDrugs. 2008;22(2):121-36. doi: 10.2165/00063030-200822020-00005.

[Can we still afford progress in intensive care medicine? Re: the article from DMW 1-2/2004].

Dtsch Med Wochenschr. 2004 Jul 30;129(31-32):1698-9; author reply 1699-70. doi: 10.1055/s-2004-829020.

引用本文的文献

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.

Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD005011. doi: 10.1002/14651858.CD005011.pub4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Recombinant factor VIIa should be used in massive obstetric haemorrhage.

作者信息

Van de Velde M

机构信息

Department of Anaesthesiology, Katholieke Universiteit Leuven and University Hospitals Gasthuisberg, Leuven, Belgium.

出版信息

Int J Obstet Anesth. 2007 Oct;16(4):357-9. doi: 10.1016/j.ijoa.2007.06.002. Epub 2007 Aug 15.

DOI:10.1016/j.ijoa.2007.06.002

PMID:17702565

Abstract

摘要

相似文献

Recombinant factor VIIa should be used in massive obstetric haemorrhage.

Int J Obstet Anesth. 2007 Oct;16(4):357-9. doi: 10.1016/j.ijoa.2007.06.002. Epub 2007 Aug 15.

Recombinant factor VIIa should be used in massive obstetric haemorrhage.

Int J Obstet Anesth. 2007 Oct;16(4):354-7. doi: 10.1016/j.ijoa.2007.06.001. Epub 2007 Aug 14.

Recombinant factor VIIa in massive postpartum haemorrhage.

Int J Obstet Anesth. 2007 Jan;16(1):29-34. doi: 10.1016/j.ijoa.2006.09.001. Epub 2006 Nov 27.

Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.

Aust N Z J Obstet Gynaecol. 2008 Aug;48(4):447. doi: 10.1111/j.1479-828X.2008.00897.x.

Recombinant factor VIIa in massive obstetric haemorrhage.

Eur J Anaesthesiol. 2008 Mar;25(3):250-1. doi: 10.1017/S0265021507002712.

Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature.

BJOG. 2004 Mar;111(3):284-7. doi: 10.1111/j.1471-0528.2004.00058.x.

Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.

Pharmacoeconomics. 2007;25(12):1007-29. doi: 10.2165/00019053-200725120-00004.

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.

Anesth Analg. 2009 Dec;109(6):1908-15. doi: 10.1213/ANE.0b013e3181c039e6.

Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.

BioDrugs. 2008;22(2):121-36. doi: 10.2165/00063030-200822020-00005.

[Can we still afford progress in intensive care medicine? Re: the article from DMW 1-2/2004].

Dtsch Med Wochenschr. 2004 Jul 30;129(31-32):1698-9; author reply 1699-70. doi: 10.1055/s-2004-829020.

引用本文的文献

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.

Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD005011. doi: 10.1002/14651858.CD005011.pub4.